|
2011
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular disease. Pharmaceutical research ... |
|
2009
|
Invention
|
Compositions for treating vascular diseases characterized by nitric oxide insufficiency.
The inv... |
|
2008
|
Invention
|
Compositions and methods related to heart failure.
The invention provides methods for reducing t... |
|
|
Invention
|
Methods for reducing hospitalizations related to heart failure.
The invention provides methods f... |
|
|
Invention
|
Nitrosated and nitrosylated prostaglandins, compositions and methods of use. 1 compound, more pre... |
|
|
Invention
|
Kits of hydralazine compounds and isosorbide dinitrate and/or isosorbide mononitrate.
The presen... |
|
2007
|
Invention
|
Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use.
The inven... |
|
|
Invention
|
Use of nitric oxide adducts.
The invention provides a method for preventing adverse effects asso... |
|
|
Invention
|
Solid dosage formulations of hydralazine compounds. The invention provides solid dosage formulati... |
|
|
Invention
|
Organic nitric oxide enhancing salts of prostaglandins, compositions and methods of use. The inve... |
|
|
Invention
|
Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphis... |
|
|
Invention
|
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use. The invention pr... |
|
|
Invention
|
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate. The inven... |
|
2006
|
Invention
|
Nitric oxide enhancing glutamic acid compounds, compositions and methods of use. The invention pr... |
|
|
Invention
|
Nitric oxide enhancing pyruvate compounds, compositions and methods of use. The invention provide... |
|
|
Invention
|
Furoxan compounds, compositions and methods of use. The invention provides novel furoxan compound... |
|
|
Invention
|
Genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase pr... |
|
|
Invention
|
Genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic recep... |
|
|
Invention
|
Methods for treating respiratory disorders.
The invention provides methods for treating respirat... |
|
|
Invention
|
The genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic re... |
|
|
Invention
|
Methods for treating respiratory disorders. The invention provides methods for treating respirato... |
|
|
Invention
|
The genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase... |
|
|
Invention
|
Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use. The ... |
|
|
Invention
|
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use. The invention de... |
|
|
Invention
|
Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and me... |
|
|
Invention
|
Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, composit... |
|
|
Invention
|
Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and... |
|
|
Invention
|
Genetic risk assessment in heart failure: impact of the genetic variation of nos3.
The invention... |
|
|
Invention
|
The genetic risk assessment in heart failure: impact of the genetic variation of nos3. The invent... |
|
|
Invention
|
Organic nitric oxide enhancing salts of angiotensin converting enzyme inhibitors, compositions an... |
|
|
Invention
|
2-methyl indole cyclooxygenase-2 selective inhibitors, compositions and methods of use. The inven... |
|
|
Invention
|
Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of u... |
|
|
Invention
|
Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of us... |
|
|
Invention
|
Nitric oxide enhancing diuretic compounds, compositions and methods of use. The invention describ... |
|
|
Invention
|
Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use. The... |
|
|
Invention
|
Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and method... |
|
2005
|
Invention
|
Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of... |
|
|
Invention
|
Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic d... |
|
|
Invention
|
Compositions and methods using apocynin compounds and nitric oxide donors. The invention describe... |
|
|
Invention
|
Compositions and methods related to heart failure. The present invention is directed, in general,... |
|
|
Invention
|
Methods for treating blood disorders with nitric oxide donor compounds.
The invention describes ... |
|
2004
|
Invention
|
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use.
The inven... |
|
2003
|
Invention
|
Methods of treating vascular diseases characterized by nitric oxide insufficiency. The invention ... |
